Evaluation of a Patient Decision Aid for Emergency Department Initiated Buprenorphine
Part of paid clinical trials in Charleston, South Carolina.
- Sponsor
- Medical University of South Carolina
- Study ID
- NCT07278518
- Status
- Recruiting
Conditions
- Opioid Use Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Patient Decision Aid for Opioid Use Disorder — BEHAVIORALThis will include information structured for patients about buprenorphine as a treatment options in the emergency department.
Study Details
This study aims to develop and pilot test a patient decision aid (PtDA) for emergency department (ED)-initiated buprenorphine treatment for opioid use disorder (OUD). The PtDA will be evaluated for acceptability, impact on patient knowledge, decisional conflict, and buprenorphine uptake compared to treatment as usual (TAU).
Key Dates
- First listed
- Dec 12, 2025
- Start date
- May 19, 2026
- Status verified
- Mar 2026
- Primary completion
- Oct 30, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 20 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- HEALTH_SERVICES_RESEARCH
Arms
- Experimental: Patient Decision AidThis arm will receive the patient decision aid
- No Intervention: Treatment as UsualThis will be treatment as usual without the patient decision aid
Primary Outcome Measure
Acceptability of Intervention Measure (AIM) [ Time Frame: Day 1 ]
Central Contacts
- Lindsey Jennings, MD, MPH(843) 876-8023
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Medical University of South Carolina | Charleston | South Carolina | 29425 |
Find similar trials in Charleston, SC
By research site
Related Studies
- Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUDRecruiting · Medical University of South Carolina · Charleston, South Carolina
- Integrated Treatment for Opioid Use Disorder and PTSDRecruiting · Medical University of South Carolina · Charleston, South Carolina
- Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use DisorderPHASE2 · Recruiting · T. John Winhusen, PhD · Jacksonville, Florida
- Technology-Enhanced Therapy vs. Medication Monitoring for Buprenorphine Retention in Pregnant PersonsRecruiting · Medical University of South Carolina · Charleston, South Carolina